PLXNA1

Chr 3AR

plexin A1

Also known as: DWOPNED, NOV, NOVP, PLEXIN-A1, PLXN1

Predicted to enable semaphorin receptor activity. Predicted to be involved in several processes, including T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell; nervous system development; and semaphorin-plexin signaling pathway. Predicted to act upstream of or within dichotomous subdivision of terminal units involved in salivary gland branching; neuron projection extension; and regulation of smooth muscle cell migration. Located in cytosol and nucleoplasm. [provided by Alliance of Genome Resources, Jul 2025]

OMIMResearchGenerating clinical summary…
LOFmechanismARLOEUF 0.261 OMIM phenotype
Clinical SummaryPLXNA1
Population Constraint (gnomAD)
Highly constrained gene — heterozygous loss-of-function variants are very rare in the population (pLI 1.00). One damaged copy is likely sufficient to cause disease.
📋
ClinVar Variants
17 unique Pathogenic / Likely Pathogenic· 523 VUS of 1054 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Dual constrained — LoF & missense intolerant
LoF Constraint?
0.26LOEUF
pLI 1.000
Z-score 7.21
OE 0.17 (0.110.26)
Highly constrained

Highly LoF-intolerant (top ~10% of genes)

Missense Constraint?
3.45Z-score
OE missense 0.73 (0.690.77)
928 obs / 1274.4 exp
Constrained

Highly missense-constrained (top ~0.1%)

Observed / Expected Ratios?
LoF OE?0.17 (0.110.26)
00.351.4
Missense OE?0.73 (0.690.77)
00.61.4
Synonymous OE?1.07
01.21.6
LoF obs/exp: 15 / 88.1Missense obs/exp: 928 / 1274.4Syn Z: -1.34
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
limitedPLXNA1-related neurodevelopmental disorderLOFAR
limitedPLXNA1-related neurodevelopmental disorder with seizuresOTHERAD

This gene — mechanism propensity

DN
0.4091th %ile
GOF
0.5660th %ile
LOF
0.60top 25%

This gene has evidence for multiple mechanisms of pathogenicity (loss-of-function and dominant-negative). Both the Badonyi & Marsh prediction and the broader genomic evidence point to loss-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

LOF76% of P/LP variants are LoF · LOEUF 0.26
DN1 literature citation

Literature Evidence

DNConclusion: We propose that different biallelic and monoallelic variants in PLXNA1 result in a novel neurodevelopmental syndrome mainly comprising developmental delay, brain, and eye anomalies. We hypothesize that biallelic variants in the extracellular Plexin-A1 domains lead to impaired dimerizatio1

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312. Mechanism ranking also informed by gnomAD constraint, ClinVar, and ClinGen data.

References

  1. 1.PMID 34054129

ClinVar Variant Classifications

1054 submitted variants in ClinVar

Classification Summary

Pathogenic5
Likely Pathogenic12
VUS523
Likely Benign425
Benign51
Conflicting11
5
Pathogenic
12
Likely Pathogenic
523
VUS
425
Likely Benign
51
Benign
11
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
5
0
0
0
5
Likely Pathogenic
8
4
0
0
12
VUS
7
494
12
10
523
Likely Benign
0
24
90
311
425
Benign
0
3
19
29
51
Conflicting
11
Total205251213501,027

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

11 pathogenic / likely-pathogenic (of 17) ClinVar copy-number / structural variants overlap PLXNA1 — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

PLXNA1 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →